알코올 금단 증후군과 알코올 금단 발작의 관리
Management of Alcohol Withdrawal Syndrome and Alcohol Withdrawal Seizure
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Alcohol withdrawal syndrome (AWS) is a common condition occurring after intentional or unintentional abrupt cessation of alcohol in an alcohol-dependent individual. AWS represents a major problem in our society and alcohol withdrawal seizure is the major cause of seizures encountered by neurology residents in the emergency department. Patients with AWS present with mild symptoms of tremulousness and agitation or more severe symptoms including withdrawal seizures and delirium tremens. Particularly, severe AWS can produce significant rates of the morbidity (complications) and mortality. When diagnosed and managed insufficiently, the morbidity and mortality rates increase. Nevertheless, patients with AWS may be neglected and are often marginalized and the teaching about AWS to neurology residents is usually minimal. Also, attending neurologists are often poorly informed on the topic. Although there is insufficient consensus about the optimal investigation and management, the purpose of this review is to serve as a summary of the appropriate identification and management of this important condition in a neurological setting.
Abstract
Alcohol withdrawal syndrome (AWS) is a common condition occurring after intentional or unintentional abrupt cessation of alcohol in an alcohol-dependent individual. AWS represents a major problem in our society and alcohol withdrawal seizure is the major cause of seizures encountered by neurology residents in the emergency department. Patients with AWS present with mild symptoms of tremulousness and agitation or more severe symptoms including withdrawal seizures and delirium tremens. Particularly, severe AWS can produce significant rates of the morbidity (complications) and mortality. When diagnosed and managed insufficiently, the morbidity and mortality rates increase. Nevertheless, patients with AWS may be neglected and are often marginalized and the teaching about AWS to neurology residents is usually minimal. Also, attending neurologists are often poorly informed on the topic. Although there is insufficient consensus about the optimal investigation and management, the purpose of this review is to serve as a summary of the appropriate identification and management of this important condition in a neurological setting.
참고문헌 (10)
- Kriss JP, "Hypothyroidism and thyroid hyperplasia in patients treated with cobalt", J Am Med Assoc, 157, pp.117~121 (1955)
- Alexander CS, "Cobalt-beer cardiomyopathy. A clinical and pathologic study of twenty-eight cases", Am J Med, 53, pp.395~417 (1972)
- Ikeda T, "Polyneuropathy caused by cobalt-chromium metallosis after total hip replacement", Muscle Nerve, 42, pp.140~143 (2010)
- Megaterio S, "Effetti a distanza del rilascio di ioni metallo in usura della testa protesica: presentazione di un caso", GIOT, 27, pp.173~175 (2001)
- Pelclova D, "Severe cobalt intoxication following hip replacement revision: clinical features and outcome", Clin Toxicol (Phila), 50, pp.262~265 (2012)
- Rizzetti MC, "Loss of sight and sound. Could it be the hip?", Lancet, 373, pp.1052~ (2009)
- Steens W, "Severe cobalt poisoning with loss of sight after ceramic-metal pairing in a hip-a case report", Acta Orthop, 77, pp.830~832 (2006)
- Tower SS, "Arthroprosthetic cobaltism: neurological and cardiac manifestations in two patients with metal-on-metal arthroplasty", J Bone Joint Surg Am, 92, pp.2847~2851 (2010)
- Catalani S, "Neurotoxicity of cobalt", Hum Exp Toxicol, 31, pp.421~437 (2012)
- Barceloux DG, "Chromium", J Toxicol Clin Toxicol, 37, pp.173~194 (1999)